Furthermore, ANGPTL4 improved glucose tolerance and IR by downregulating insulin signaling pathway-associated genes, such as Akt, Janus kinase 2/signal transducer and activator of transcription-3 (JAK2/STAT3), but promoted diet-induced hepatic steatosis (23). Here, STAT3 is linked to fatty liver disease.